2012-01-04

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

International Journal for Parasitology: Drugs and Drug Resistance

by Freitas-Junior LH, Chatelain E, Kim HA, Siqueira-Neto JL. International Journal for Parasitology: Drugs and Drug Resistance, January 2012, Volume 2

Click here to read the article

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Latest scientific articles

Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay

ICH E21: from landmark guidance to specific action for maternal and child health

A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms

A serological method’s ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data

Stay connected

Learn more

Get in touch

Support us

Work with us